NDA 19437, held by Icu Medical Inc. Amino Acids; Magnesium Chloride; Potassium Chloride; Potassium Phosphate, Dibasic; Sodium Chloride, Amino Acids; Magnesium Chloride; Potassium Chloride; Sodium Chloride; Sodium Phosphate, Dibasic, Heptahydrate, Amino Acids; Magnesium Chloride; Potassium Chloride; Sodium Chloride; Sodium Phosphate, Dibasic.
As of Nov 13, 2026, NDA 19437 (Aminosyn Ii 10% W/ Electrolytes, Aminosyn Ii 8.5% W/ Electrolytes, Aminosyn Ii 7% W/ Electrolytes), held by Icu Medical Inc, was first approved by FDA on Apr 3, 1986, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 3, 1986 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
| Aminosyn Ii 10% W/ Electrolytes10%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100ML · injectable;injection | Amino Acids; Magnesium Chloride; Potassium Chloride; Potassium Phosphate, Dibasic; Sodium Chloride | Discontinued |
| Aminosyn Ii 8.5% W/ Electrolytes8.5%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100ML · injectable;injection | Amino Acids; Magnesium Chloride; Potassium Chloride; Potassium Phosphate, Dibasic; Sodium Chloride | Discontinued |
| Aminosyn Ii 7% W/ Electrolytes7%;102MG/100ML;45MG/100ML;522MG/100ML;410MG/100ML · injectable;injection | Amino Acids; Magnesium Chloride; Potassium Chloride; Potassium Phosphate, Dibasic; Sodium Chloride | Discontinued |
| Aminosyn Ii 3.5% M3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100ML · injectable;injection | Amino Acids; Magnesium Chloride; Potassium Chloride; Sodium Chloride; Sodium Phosphate, Dibasic, Heptahydrate | Discontinued |
| Aminosyn Ii 8.5% W/Electrolytes8.5%;102MG/100ML;492MG/100ML;60MG/100ML;425MG/100ML · injectable;injection | Amino Acids; Magnesium Chloride; Potassium Chloride; Sodium Chloride; Sodium Phosphate, Dibasic | Discontinued |
| Jun 6, 2016 | Supplement 38Manufacturing · Standard review | Approved | None posted |
| Jul 31, 2013 | Supplement 34Manufacturing · Standard review | Approved | None posted |
| Jun 23, 2003 | Supplement 14Labeling · Standard review | Approved | |
| Oct 25, 2002 | Supplement 15Manufacturing · Standard review | Approved | |
| Jan 22, 1999 | Supplement 13Manufacturing · Standard review | Approved | None posted |
| May 5, 1997 | Supplement 12Manufacturing · Standard review | Approved | None posted |
| Aug 27, 1996 | Supplement 11Manufacturing · Standard review | Approved | None posted |
| Jul 11, 1994 | Supplement 10Manufacturing · Standard review | Approved | None posted |
| Dec 30, 1993 | Supplement 9Manufacturing · Standard review | Approved | None posted |
| Sep 28, 1992 | Supplement 8Manufacturing · Standard review | Approved | None posted |
| Aug 18, 1992 | Supplement 7Manufacturing · Standard review | Approved | None posted |
| Feb 10, 1992 | Supplement 6Manufacturing · Standard review | Approved | None posted |
| Jun 17, 1988 | Supplement 5Labeling | Approved | None posted |
| Dec 1, 1987 | Supplement 4Manufacturing · Standard review | Approved | None posted |
| Dec 4, 1986 | Supplement 1Manufacturing · Standard review | Approved | None posted |
| Dec 4, 1986 | Supplement 2Labeling | Approved | None posted |
| Apr 3, 1986 | Original applicationNew formulation or manufacturer · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters